Genetic alterations in RAS-regulated pathway in acral lentiginous melanoma

Experimental Dermatology

Volumn 22, Issue 2, 2013, Pages 148-150

  Puig Butillé, Joan A ^a,b   Badenas, Celia ^a,b   Ogbah, Zighereda ^b   Carrera, Cristina ^a,b   Aguilera, Paula ^a,b   Malvehy, Josep ^a,b   Puig, Susana ^a,b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Acral lentiginous melanoma; AURKA; Melanoma; MLPA; NRAS

Indexed keywords

B RAF KINASE; PROTEIN AURKA; PROTEIN CCND1; PROTEIN N RAS; RAS PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ACRAL LENTIGINOUS MELANOMA; APOPTOSIS; CELL CYCLE PROGRESSION; GENE AMPLIFICATION; GENE FREQUENCY; GENE MUTATION; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; MELANOMA; MISSENSE MUTATION; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL CYCLE; CHROMOSOME DELETION; CLUSTER ANALYSIS; CYCLIN D1; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; GENETIC VARIATION; GTP PHOSPHOHYDROLASES; HUMANS; MELANOMA; MEMBRANE PROTEINS; MUTATION; MUTATION, MISSENSE; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS B-RAF; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TELOMERASE;

EID: 84873209852     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12080     Document Type: Letter

References (24)

1. Bastian B C, Kashani-Sabet M, Hamm H et al. Cancer Res 2000: 60: 1968-1973.
2. Bastian B C, Olshen A B, LeBoit P E et al. Am J Pathol 2003: 163: 1765-1770.
3. Curtin J A, Fridlyand J, Kageshita T et al. N Engl J Med 2005: 353: 2135-2147.
4. Wurm E M, Lin L L, Ferguson B et al. Exp Dermatol 2012: 21: 676-681.
5. Whiteman D C, Pavan W J, Bastian B C. Pigment Cell Melanoma Res 2011: 24: 879-897.
6. Sauter E R, Yeo U C, von Stemm A et al. Cancer Res 2002: 62: 3200-3206.
7. Takata M, Goto Y, Ichii N et al. J Invest Dermatol 2005: 125: 318-322.
8. Curtin J A, Busam K, Pinkel D et al. J Clin Oncol 2006: 24: 4340-4346.
9. Jonsson G, Dahl C, Staaf J et al. Oncogene 2007: 26: 4738-4748.
10. Ruiz A, Puig S, Lynch M et al. Int J Cancer 1998: 76: 312-316.
11. Kumar R, Smeds J. Melanoma Res 1999: 9: 138-147.
12. Scope A, Busam K J, Malvehy J et al. Arch Dermatol 2007: 143: 1548-1552.
13. Reifenberger J, Knobbe C B, Sterzinger A A et al. Int J Cancer 2004: 109: 377-384.
14. Takata M, Lin J, Takayanagi S et al. Br J Dermatol 2007: 156: 1287-1294.
15. Chernoff K A, Bordone L, Horst B et al. Clin Cancer Res 2009: 15: 4288-4291.
16. Koynova D K, Jordanova E S, Milev A D et al. Melanoma Res 2007: 17: 37-41.
17. Zhou H, Kuang J, Zhong L et al. Nat Genet 1998: 20: 189-193.
18. Tanaka E, Hashimoto Y, Ito T et al. Clin Cancer Res 2005: 11: 1827-1834.
19. Yao J E, Yan M, Guan Z et al. Mol Cancer 2009: 8: 95.
20. Lim K H, Brady D C, Kashatus D F et al. Mol Cell Biol 2009: 30: 508-523.
21. Lim K H, Baines A T, Fiordalisi J J et al. Cancer Cell 2005: 7: 533-545.
22. Glatz-Krieger K, Pache M, Tapia C et al. Virchows Arch 2006: 449: 328-333.
23. Stark M, Hayward N. Cancer Res 2007: 67: 2632-2642.
24. Maldonado J L, Fridlyand J, Patel H et al. J Natl Cancer Inst 2003: 95: 1878-1890.